As of Sep 27
| +0.08 / +1.16%|
The 2 analysts offering 12-month price forecasts for Enzymotec Ltd have a median target of 7.75, with a high estimate of 8.00 and a low estimate of 7.50. The median estimate represents a +10.71% increase from the last price of 7.00.
The current consensus among 3 polled investment analysts is to Buy stock in Enzymotec Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.